Munafa Stock Market Course + Intraday & FNO calls 
Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Array Biopharma (ARRY)
Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 20 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma
Array Biopharma Opened at 6.13 and Closed at: 5.95, which is -2.69% of previous session's close. It moved within a range of 5.80 and 6.14
The session was a Bearish session with an average volume of 8048400, which is -56.75% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 5.71 and resistance for tomorrow is 6.05
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 5.79, 5.62 resistance for tomorrow's hourly charts is 6.13, 6.3
10 Day SMA for Array Biopharma (ARRY) is 6.29 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Array Biopharma (ARRY) is 6.88 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Array Biopharma (ARRY) is 7.76 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.65 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Array Biopharma is 8.49 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Array Biopharma is at 6.88 and 200 DMA is at 8.49, while 50 DMA and 100 DMA are at 7.76 and 7.65 respectively
Array Biopharma (ARRY) moving average of 20 SMA is at 6.88 and 20 EMA is at 6.76
| Date | Closing Price | 20 SMA | 20 EMA |
| 20 Mon Jul | 5.95 | 6.88 | 6.76 |
| 17 Fri Jul | 6.11 | 6.98 | 6.84 |
| 16 Thu Jul | 6.25 | 7.06 | 6.92 |
| 15 Wed Jul | 6.37 | 7.14 | 6.99 |
| 14 Tue Jul | 6.28 | 7.23 | 7.05 |
| 13 Mon Jul | 6.12 | 7.3 | 7.13 |
Array Biopharma (ARRY) moving average of 50 SMA is at 7.76 and 50 EMA is at 7.38
| Date | Closing Price | 50 SMA | 50 EMA |
| 20 Mon Jul | 5.95 | 7.76 | 7.38 |
| 17 Fri Jul | 6.11 | 7.8 | 7.44 |
| 16 Thu Jul | 6.25 | 7.84 | 7.49 |
| 15 Wed Jul | 6.37 | 7.88 | 7.54 |
| 14 Tue Jul | 6.28 | 7.9 | 7.59 |
| 13 Mon Jul | 6.12 | 7.94 | 7.64 |
Array Biopharma (ARRY) moving average of 100 SMA is at 7.65 and 100 EMA is at 7.81
| Date | Closing Price | 100 SMA | 100 EMA |
| 20 Mon Jul | 5.95 | 7.65 | 7.81 |
| 17 Fri Jul | 6.11 | 7.69 | 7.85 |
| 16 Thu Jul | 6.25 | 7.74 | 7.89 |
| 15 Wed Jul | 6.37 | 7.79 | 7.92 |
| 14 Tue Jul | 6.28 | 7.84 | 7.95 |
| 13 Mon Jul | 6.12 | 7.89 | 7.98 |
Array Biopharma (ARRY) moving average of 200 SMA is at 8.49 and 200 EMA is at 7.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 20 Mon Jul | 5.95 | 8.49 | 7.94 |
| 17 Fri Jul | 6.11 | 8.5 | 7.96 |
| 16 Thu Jul | 6.25 | 8.51 | 7.98 |
| 15 Wed Jul | 6.37 | 8.52 | 8 |
| 14 Tue Jul | 6.28 | 8.53 | 8.02 |
| 13 Mon Jul | 6.12 | 8.54 | 8.04 |
Nu Skin has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Nu Skin, about 36.93% more returns!
Cigna Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Cigna Corporation, about 30.99% more returns!
Neuronetics Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Neuronetics Inc, about 98.66% more returns!
Sensus Healthcare has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Sensus Healthcare, about 42.24% more returns!
Solid Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Solid Biosciences, about 32.14% more returns!
Inmune Bio has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Inmune Bio, about 69.49% more returns!
Inogen Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Inogen Inc, about 29.86% more returns!
Immutep has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Immutep, about 38.22% more returns!
Immucell Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Immucell Corporation, about 44.69% more returns!
Integra Lifesciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Integra Lifesciences, about 37.66% more returns!
Helius Medical has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Helius Medical, about 41.37% more returns!
Fortress Biotech has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Fortress Biotech, about 38.45% more returns!
Editas Medicine has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Editas Medicine, about 33.19% more returns!
Electrocore Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Electrocore Inc, about 5.08% more returns!
Champions Oncology has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Champions Oncology, about 27.93% more returns!
Co Diagnostics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Co Diagnostics, about 8.54% more returns!
Cocrystal Pharma has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 23.33% more returns!
Compugen has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Compugen, about 43.37% more returns!
Biotelemetry Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 10.61% more returns!
Array Biopharma Technical analysis of indicators
Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.25 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARRY Experts View which covers a lot of information including buying and selling signals
ARRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
